Valuation: Supriya Lifescience Limited

Market Cap 69.4B 729M 653M 603M 547M 1.02B 1.03B 7.21B 2.87B 36.32B 2.73B 2.68B 115B P/E 2027 *
29.2x
P/E 2028 * 22.2x
Enterprise Value 69.4B 729M 653M 603M 547M 1.02B 1.03B 7.21B 2.87B 36.32B 2.73B 2.68B 115B EV / Sales 2027 *
6.99x
EV / Sales 2028 * 5.59x
Free-Float
28.72%
Yield 2027 *
-
Yield 2028 * -
1 day+1.33%
1 week-1.26%
Current month-9.26%
1 month-12.48%
3 months+2.05%
6 months+22.40%
Current year+14.74%
1 week 801
Extreme 801
879.2
1 month 801
Extreme 801
1,019.8
Current year 545.5
Extreme 545.5
1,085
1 year 545.5
Extreme 545.5
1,085
3 years 239.8
Extreme 239.8
1,085
5 years 170.15
Extreme 170.15
1,085
10 years 170.15
Extreme 170.15
1,085
Manager TitleAgeSince
Chief Executive Officer 35 31/07/2024
Chief Executive Officer 36 31/07/2024
Director of Finance/CFO - 22/01/2023
Director TitleAgeSince
Chairman 70 25/03/2008
Director/Board Member 41 31/05/2019
Director/Board Member 36 31/05/2019
Change 5-day change 1-year change 3-year change Capi.($)
+1.33%-1.26% - - 721M
Average +1.33%
Weighted average by Cap. +1.33%

Financials

2027 *2028 *
Net sales 9.94B 104M 93.53M 86.36M 78.32M 146M 148M 1.03B 411M 5.2B 391M 383M 16.47B 12.42B 130M 117M 108M 97.89M 183M 185M 1.29B 514M 6.5B 489M 479M 20.59B
Net income 2.37B 24.91M 22.33M 20.62M 18.7M 34.87M 35.32M 246M 98.21M 1.24B 93.46M 91.5M 3.93B 3.12B 32.79M 29.39M 27.14M 24.61M 45.89M 46.48M 324M 129M 1.63B 123M 120M 5.18B
Net Debt - -
Projected Income Statement - Annual - Supriya Lifescience Limited
Logo Supriya Lifescience Limited
Supriya Lifescience Limited is an India-based manufacturer of active pharmaceutical ingredients (APIs). The Company is primarily engaged in the manufacturing of bulk drugs and pharmaceutical chemicals. The Company exports its products in the antihistamine, anesthetics and anti-asthma therapy categories to approximately 86 countries. The Company's product portfolio consists of approximately 38 API products that offer remedies in therapeutic segments, such as antihistamines, analgesics, vitamins, anesthetics and anti-asthmatics, among others. Its products include Chlorphenamine Maleate, Pheniramine Maleate, Brompheniramine Maleate, Dexchlorpheniramine Maleate, Mepyramine / Pyrilamine Maleate, Dexbrompheniramine Maleate, Cetirizine DiHCL, Diphenhydramine HCL, Bisoprolol Fumarate, Nicorandil, Mecobalamin, Hydroxocobalamin Sulfate, Hydroxocobalamin Acetate, and Hydroxocobalamin Hydrochloride, among others. The Company has manufacturing facilities located in Maharashtra.
Employees
607
Date Price Change Volume
28/10/26 ₹862.25 +1.33% 199,541
27/10/26 ₹850.90 +2.14% 91,955
26/10/26 ₹833.05 +1.77% 90,442
23/10/26 ₹818.55 -2.12% 162,923
22/10/26 ₹836.25 -0.75% 112,881

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Supriya Lifescience Limited
  1. Stock Market
  2. Stocks
  3. SUPRIYA Stock